These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16304802)

  • 21. Antithrombotics in atrial fibrillation and coronary disease.
    Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation?
    Gorelick PB
    Stroke; 2007 May; 38(5):1652-4. PubMed ID: 17395857
    [No Abstract]   [Full Text] [Related]  

  • 23. [EBM of cerebral infarction: message from mega-studies].
    Uchiyama S
    Rinsho Shinkeigaku; 2003 Nov; 43(11):884-6. PubMed ID: 15152493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation, is warfarin the only option for stroke prevention?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Mar; 61(3):301-2. PubMed ID: 21465955
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation.
    Manaktala R; Kluger J
    J Am Osteopath Assoc; 2017 Dec; 117(12):761-771. PubMed ID: 29181519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Indications for anticoagulant use in secondary prevention of strokes].
    Gere J; Minier D; Osseby GV; Couvreur G; Moreau T; Giroud M
    Presse Med; 2003 Jul; 32(25):1175-80. PubMed ID: 13677881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation, is warfarin the only option for stroke prevention?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Apr; 61(4):406-7. PubMed ID: 21465988
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clopidogrel and stroke].
    Rodríguez-Yáñez M; Arias-Rivas S; Fernández-Ferro J; Leira R; Castillo J; Blanco M
    Rev Neurol; 2011 Nov; 53(9):561-73. PubMed ID: 22012820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?
    Asencio LA; Huang JJ; Alpert JS
    Am J Med; 2014 Jul; 127(7):579-85. PubMed ID: 24608021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PRoFESS trial: future impact on secondary stroke prevention.
    Diener HC
    Expert Rev Neurother; 2007 Sep; 7(9):1085-91. PubMed ID: 17868007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trials of newer approaches to anticoagulation in atrial fibrillation.
    Cooper HA
    J Interv Card Electrophysiol; 2004; 10 Suppl 1():27-31. PubMed ID: 14739737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New possibilities in anticoagulant management of atrial fibrillation.
    Waldo AL
    Rev Cardiovasc Med; 2004; 5 Suppl 5():S30-8. PubMed ID: 15619613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the best first agent to give to a patient with acute ischaemic stroke? Aspirin, heparin, clopidogrel, cilostazol or dipyridamole?
    Khan M; Kamal AK
    J Pak Med Assoc; 2010 Oct; 60(10):877-8. PubMed ID: 21381628
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiplatelet therapy in cerebrovascular disorders.
    Weber R; Brenck J; Diener HC
    Handb Exp Pharmacol; 2012; (210):519-46. PubMed ID: 22918745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.
    Shrestha S; Coy S; Bekelis K
    Curr Pharm Des; 2017; 23(9):1377-1391. PubMed ID: 28003013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.